Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology

A study of cannabis potency in France over a 25 years period (1992–2016)

(2017) Laurence Dujourdy et al.   FORENSIC SCIENCE INTERNATIONAL

US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws

(2017) Deborah S. Hasin et al.   JAMA Psychiatry

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

(2016) Arianna Marconi et al.   SCHIZOPHRENIA BULLETIN

Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis

(2016) Robin M. Murray et al.   World Psychiatry

Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15

(2015) Raymond J. M. Niesink et al.   ADDICTION

Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

(2014) Tom P. Freeman et al.   ADDICTION

Cannabis Use and Earlier Onset of Psychosis

(2011) Matthew Large et al.   ARCHIVES OF GENERAL PSYCHIATRY

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

(2011) Ethan B Russo   BRITISH JOURNAL OF PHARMACOLOGY

Cannabis use in young people: The risk for schizophrenia

(2011) Paola Casadio et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology

(2008) David J. Potter et al.   JOURNAL OF FORENSIC SCIENCES